Aurobindo Pharma Ltd (ARBN.NS) Analyst Research| Reuters.com
Edition:
United States

Aurobindo Pharma Ltd (ARBN.NS)

ARBN.NS on National Stock Exchange of India

738.00INR
29 Jun 2016
Change (% chg)

-- (--)
Prev Close
Rs738.00
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
1,971,125
52-wk High
Rs891.50
52-wk Low
Rs582.00

Reports per page
Select Report Title Date Provider Pgs Price
Thomson Reuters Stock Report - Aurobindo Pharma Ltd (AUROPHARMA-IN) 5:15am EDT Thomson Reuters Stock Report 11 25.00
Aurobindo Pharma Ltd: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. 24 Jun 2016 Reuters Investment Profile 12 20.00
Wright Investors Service Comprehensive Report for Aurobindo Pharma Ltd 3 Jun 2016 Wright Reports 60 75.00
MOSL: AUROBINDO PHARMA 4QFY16 (Buy)-Results in line with estimates-US business’ growth momentum to continue 1 Jun 2016 Motilal Oswal Securities Ltd. 12 115.00
Aurobindo Pharma (ARBP)_Q4FY16 Result Update 31 May 2016 IndiaNivesh Securities Pvt Ltd 7 69.00
Spark Capital: 4QFY16 outlook review of Aurobindo Pharma (Rating: BUY, TP: Rs. 902) 31 May 2016 Spark Capital Advisors(India) Private Limited 6 46.00
Aurobindo Pharma Ltd_Q4FY16 Result Flash Note 31 May 2016 IndiaNivesh Securities Pvt Ltd 2 12.00
Aurobindo Pharma (ARBP) - Qtr. Update - Dated - May 31, 2016 31 May 2016 Axis Capital Limited 8 81.00
Thomson Reuters Stock Report - Aurobindo Pharma Ltd (AUROPHARMA-IN) 10 May 2016 Thomson Reuters Stock Report 11 25.00
 
Name Age Since Current Position

K. Ragunathan

52 2012 Non-Executive Independent Chairman of the Board

K. Nityananda Reddy

57 2012 WholeTime Vice Chairman of the Board

Santhanam Subramanian

2014 Chief Financial Officer

B. Adi Reddy

2016 Compliance Officer, Company Secretary

N. Govindarajan

47 2012 Managing Director, Executive Director